Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease

International Journal of COPD

Volumn 10, Issue , 2015, Pages 389-397

  Geiger Brown, Jeanne ^a   Lindberg, Sarah ^b   Krachman, Samuel ^c   McEvoy, Charlene E ^d   Criner, Gerard J ^c   Connett, John E ^b   Albert, Richard K ^e   Scharf, Steven M ^f  

^a UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Health Partners Institute of education and research   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Pittsburgh Sleep Quality Index; SF 36; St George s Respiratory Questionnaire

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; HYPNOTIC AGENT; MUSCARINIC AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; OXYGEN; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PITTSBURGH SLEEP QUALITY INDEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; SLEEP QUALITY; SLEEP TIME; ST. GEORGE RESPIRATORY QUESTIONNAIRE; ACUTE DISEASE; COMPLICATION; CONTROLLED STUDY; DISEASE COURSE; MIDDLE AGED; PATHOPHYSIOLOGY; POLYPHARMACY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP WAKE DISORDERS; TIME;

ACUTE DISEASE; AGED; COMORBIDITY; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; POLYPHARMACY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP WAKE DISORDERS; TIME FACTORS;

EID: 84923314876     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S75840     Document Type: Article

References (30)

1. Hajiro T, Nishimura K, Tsukino Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of participants with COPD. Chest. 1999;116(6):1632–1637.
2. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in participants with chronic obstructive pulmonary disease. Chron Respir Dis. 2005;2(4):183–191.
3. Mahler DA, Faryniarz K, Tomlinson D, et al. Impact of dyspnea and physiologic function on general health status in participants with chronic obstructive pulmonary disease. Chest. 1992;102(2):395–401.
4. Nunes DM, Mota RMS, de Pontes Neto OL, Pereira ED, de Bruin VM, de Bruin PF. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159–163.
5. McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology. 2012;17(7):1119–1124.
6. Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2010;6:1–12.
7. Krachman S, Minai O, Scharf SM. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc. 2008;5(4):536–542.
8. Agusti A, Hedner J, Marin JM, Barbé F, Cazzola M, Rennard S. Nighttime symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(121):183–194.
9. Tsai CL, Brenner BE, Camargo CA. Circadian-rhythm differences among emergency department participants with chronic obstructive pulmonary disease exacerbation. Chronobiol Int. 2007;24(4):699–713.
10. Kwon JS, Wolfe LF, Lu BS, Kalhan R. Hyperinfation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD. 2009;6(6):441–445.
11. McNicholas WT, Verbraeken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2013;22(129):365–375.
12. Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13(5):476–483.
13. Kent BD, McNicholas WT, Verbraecken J. Disturbed sleep and COPD outcomes: cart meets horse. Sleep Med. 2012;13(5):453–454.
14. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of COPD exacerbations. N Engl J Med. 2011;365(8):689–698.
15. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):192–213.
16. Strategy for the Diagnosis, Management and Prevention of COPD. Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/. Accessed January 7, 2015.
17. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classifcation and DDD assignment 2013. Oslo, Norway: World Health Organization; 2010. Available from: http://www.whocc.no/flearchive/publications/1_2013guidelines.pdf. Accessed January 7, 2015.
18. Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005;143(5):317–326.
19. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airfow limitation: the St George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6): 1321–1327.
21. Meguro M, Barley EA, Spencer S, Jones P W. Development and validation of an improved, COPD-specifc version of the Saint George’s Respiratory Questionnaire. Chest. 2007;132(2):456–463.
22. Alattar M, Scharf SM. Opioid associated central sleep apnea. Sleep Breath. 2009;13(2):201–206.
23. Calverly PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis. 1982;126(2):206–210.
24. Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger M. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis. 1982;126(3): 429–433.
25. Romem A, Iacono A, McIlmoyle E, et al. Obstructive sleep apnea in participants with end-stage lung disease. J Clin Sleep Med. 2013; 9(7):687–693.
26. Greenberg-Dotan S, Reuveni H, Tal A, et al. Increased prevalence of obstructive lung disease in participants with obstructive sleep apnea. Sleep Breath. 2014;18(1):69–75.
27. Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122(8):778.e9–e15.
28. Czeisler CA. Impact of sleepiness and sleep defciency on public health – utility of biomarkers. J Clin Sleep Med. 2011;7(5 Suppl): S6–S8.
29. Phillips BA, Cooper KR, Burke TV. The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest. 1967;91(1): 29–32.
30. Mastronarde JG, Wise RA, Shade DM, Colopade CO, Scharf SM. Sleep quality in asthma: results of a large prospective clinical trial. J Asthma. 2008;45(3):183–189.